Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Decreased risk of cancer in multiple sclerosis patients and analysis of the effect of disease modifying therapies on cancer risk.

Journal of the neurological sciences - 15 Nov 2016

Gaindh Deeya, Kavak Katelyn S, Teter Barbara, Vaughn Caila B, Cookfair Diane, Hahn Theresa, Weinstock-Guttman Bianca

Abstract excerpt

BACKGROUND: Although dysimmunity is considered an important link between multiple sclerosis (MS), family history and cancer risk, their relationship to the use of disease modifying therapies (DMT) is not fully understood. OBJECTIVE: To assess the observed versus expected number of cancers in MS patients, and family history of cancer, among DMT users and DMT naïve patients. METHODS: Cancer, DMT use, and family...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Immunologic Factors
Share to Incidence

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Longitudinal Studies

Share to Multiple Sclerosis

Share to New York

Share to Registries

Share to Self Report

Source

Identifiers

PMID: 27772741
DOI: 10.1016/j.jns.2016.09.005

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Decreased risk of cancer in multiple sclerosis patients and analysis of the effect of disease modifying therapies on cancer risk.PMID 27772741Read ↗

Cancer risk among patients with multiple sclerosis and their parents.Semantic proximity Read ↗

Autoimmune disease in families with multiple sclerosis: a population-based study.Semantic proximity Read ↗

Association of Vitamin C Supplementation and Genetic Susceptibility with Multiple Sclerosis Risk: A Prospective Population-Based Cohort Study.Semantic proximity Read ↗

Shared genetic factors may not explain the raised risk of comorbid inflammatory diseases in multiple sclerosis.Semantic proximity Read ↗

The Relation of Multiple Sclerosis to Family History, Lifestyle, and Health Factors in Childhood and Adolescence: Findings of a Case-Control Study Nested Within the German National Cohort (NAKO) Study.Semantic proximity Read ↗

Case Report: A case of immune checkpoint inhibitor therapy in a patient with multiple sclerosisSemantic proximity Read ↗

Neurologic outcomes in people with multiple sclerosis treated with immune checkpoint inhibitors for oncologic indicationsSemantic proximity Read ↗

Familial risk of multiple sclerosis: a nationwide cohort study.Semantic proximity Read ↗

Allergy, family history of autoimmune diseases, and the risk of multiple sclerosis.Semantic proximity Read ↗

Why is immunotherapy effective (or not) in patients with MSI/MMRD tumors?Semantic proximity Read ↗

MS Sunshine Study: Sun Exposure But Not Vitamin D Is Associated with Multiple Sclerosis Risk in Blacks and Hispanics.Semantic proximity Read ↗

Low sun exposure increases multiple sclerosis risk both directly and indirectly.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.